Co-targeting ASK1 and THRbeta synergistically improves steatohepatitis and fibrosis in a MASH animal model. Shang S, Wan Q, Chen F, Hu J, et al. Biochem Biophys Res Commun 2024;705:149739.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shang S, Wan Q, Chen F, Hu J, et al. Co-targeting ASK1 and THRbeta synergistically improves steatohepatitis and fibrosis in a MASH animal model. Biochem Biophys Res Commun 2024;705:149739.
PMID: 38460439